PharmacoEconomics & Outcomes News Weekly


ISSN: 1173-5503        年代:2003
当前卷期:Volume &NA;  issue 443     [ 查看所有卷期 ]

年代:2003
 
     Volume 421  issue &NA;   
     Volume &NA;  issue 394   
     Volume &NA;  issue 395   
     Volume &NA;  issue 396/397   
     Volume &NA;  issue 398   
     Volume &NA;  issue 399   
     Volume &NA;  issue 400   
     Volume &NA;  issue 401   
     Volume &NA;  issue 402   
     Volume &NA;  issue 403   
     Volume &NA;  issue 404   
     Volume &NA;  issue 405   
     Volume &NA;  issue 406   
     Volume &NA;  issue 407   
     Volume &NA;  issue 408/09   
     Volume &NA;  issue 410   
     Volume &NA;  issue 411   
     Volume &NA;  issue 412   
     Volume &NA;  issue 413   
     Volume &NA;  issue 414   
     Volume &NA;  issue 415   
     Volume &NA;  issue 416   
     Volume &NA;  issue 417   
     Volume &NA;  issue 418   
     Volume &NA;  issue 419   
     Volume &NA;  issue 420   
     Volume &NA;  issue 422   
     Volume &NA;  issue 423   
     Volume &NA;  issue 424   
     Volume &NA;  issue 425   
     Volume &NA;  issue 426   
     Volume &NA;  issue 427   
     Volume &NA;  issue 428   
     Volume &NA;  issue 429   
     Volume &NA;  issue 430   
     Volume &NA;  issue 431   
     Volume &NA;  issue 432   
     Volume &NA;  issue 433   
     Volume &NA;  issue 434   
     Volume &NA;  issue 435   
     Volume &NA;  issue 436   
     Volume &NA;  issue 437   
     Volume &NA;  issue 438   
     Volume &NA;  issue 439   
     Volume &NA;  issue 440   
     Volume &NA;  issue 441   
     Volume &NA;  issue 442   
     Volume &NA;  issue 443
1. Free antiretrovirals in India premature, say observers
  PharmacoEconomics & Outcomes News Weekly,   Volume  &NA;,   Issue  443,   2003,   Page  2-2

&NA;,  

Preview

2. Long-acting risperidone adds value in schizophrenia
  PharmacoEconomics & Outcomes News Weekly,   Volume  &NA;,   Issue  443,   2003,   Page  3-4

L Hunt,  

Preview

3. Variation in drug sales across Europe
  PharmacoEconomics & Outcomes News Weekly,   Volume  &NA;,   Issue  443,   2003,   Page  4-4

&NA;,  

Preview

4. Stenting worth it, but value of abciximab uncertain
  PharmacoEconomics & Outcomes News Weekly,   Volume  &NA;,   Issue  443,   2003,   Page  5-5

&NA;,  

Preview

5. Gastroprotective agents underused in The Netherlands
  PharmacoEconomics & Outcomes News Weekly,   Volume  &NA;,   Issue  443,   2003,   Page  6-6

&NA;,  

Preview

6. CYP2C19 genotyping worth it forH. pylorieradication in the US
  PharmacoEconomics & Outcomes News Weekly,   Volume  &NA;,   Issue  443,   2003,   Page  7-7

&NA;,  

Preview

7. Antibacterial use for bacteraemia varies widely among ICUs
  PharmacoEconomics & Outcomes News Weekly,   Volume  &NA;,   Issue  443,   2003,   Page  8-8

&NA;,  

Preview

8. Monitoring early viral response to PEG IFN-α-2b + ribavirin warranted
  PharmacoEconomics & Outcomes News Weekly,   Volume  &NA;,   Issue  443,   2003,   Page  9-9

&NA;,  

Preview

9. QOL effect of HRT plus other prescription drugs in menopause
  PharmacoEconomics & Outcomes News Weekly,   Volume  &NA;,   Issue  443,   2003,   Page  10-10

&NA;,  

Preview

10. Drug spending under the Australian Pharmaceutical Benefits Scheme (PBS) for the year ended September 2003 increased 6.9% over the same period in 2002,
  PharmacoEconomics & Outcomes News Weekly,   Volume  &NA;,   Issue  443,   2003,   Page  11-11

&NA;,  

Preview

首页 上一页 下一页 尾页 第1页 共10条